Home/Filings/3/0001683168-20-000071
3//SEC Filing

E&Investment, Inc. 3

Accession 0001683168-20-000071

CIK 0001638287other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 9:27 PM ET

Size

16.0 KB

Accession

0001683168-20-000071

Insider Transaction Report

Form 3
Period: 2019-12-30
Holdings
  • Common Stock

    (indirect: Held by The E&Healthcare Investment Fund II)
    4,335,800
  • Common Stock

    (indirect: Held by The E&Healthcare Investment Fund No. 7)
    1,864,799
  • Common Stock

    (indirect: Held by The E&Healthcare Investment Fund No. 6)
    1,121,190
Footnotes (4)
  • [F1]These shares are owned directly by The E&Healthcare Investment Fund II, a 10% owner of the Issuer, and indirectly by E&Investment, Inc., as sole general partner of The E&Healthcare Investment Fund II.
  • [F2]These shares are owned directly by The E&Healthcare Investment Fund No. 6, and indirectly by E&Investment, Inc., as sole general partner of The E&Healthcare Investment Fund No. 6
  • [F3]These shares are owned directly by The E&Healthcare Investment Fund No.7, a 10% owner of the Issuer, and indirectly by E&Investment, Inc., as sole general partner of The E&Healthcare Investment Fund No.7.
  • [F4]E&Investment, Inc. disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

Issuer

NeuroBo Pharmaceuticals, Inc.

CIK 0001638287

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001796144

Filing Metadata

Form type
3
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 9:27 PM ET
Size
16.0 KB